期刊文献+

核素全身骨显像在肾细胞癌患者术后随访中的应用价值 被引量:2

Application value of bone scintigraphy in postoperative follow-up of patients with renal cell cancer
下载PDF
导出
摘要 目的探讨核素全身骨显像在肾细胞癌(简称肾癌)患者术后随访中的应用价值,分析肾癌患者术后骨转移的相关影响因素。方法回顾性分析2000年1月至2011年1月157例随访资料完整的肾癌患者术后骨显像结果,根据病理组织学结果、CT、MRI及骨显像随访结果最终确定患者是否发生骨转移,通过单因素分析和多因素Cox模型分析性别、年龄、病理分级、病理分期、骨痛与骨转移发生的关系。结果 157例肾癌患者术后行骨显像检查,共计显像652次,每例患者骨显像次数2~12次。发生骨转移者55例,男45例,女10例。其中多发转移者42例,单发转移者13例。骨显像中转移灶表现为浓聚者35例,浓聚伴缺损者15例,缺损者5例。骨转移发生部位依次为骨盆、腰椎、肋骨、股骨、胸椎、颅骨、肱骨、肩胛骨、胸骨、胫骨、跟骨。单因素及多因素分析结果均显示,患者病理分期、骨痛与骨转移的发生密切相关,而患者的性别、年龄、病理分级、病理类型与骨转移的发生无明显关系。结论骨显像在肾癌术后骨转移的诊断中有重要的应用价值,尤其是病理分期较高、有骨痛的患者,应尽早进行骨显像,以便早期发现骨转移病灶,及时采取有效的治疗。 Objective To investigate the application value of bone scintigraphy in the postoperative follow-up of the patients with renal cell cancer(RCC) and to analyze the factors related to bone metastases.Methods To retrospectively analyze the results of postoperative bone scintigraphy in 157 cases of RCC with the complete follow up data from Jan.2000 to Jan.2011.Bone metastases were confirmed by pathology,CT,MRI and bone scintigraphy follow-up.The univariate analysis and multivariate Cox proportional hazards regression models were used to analyze the relationship between sex,age,pathological type,pathological grade,pathological stage and bone pain with bone metastses.Results 157 cases of postoperative RCC were performed 652 times bone scintigraphy,each case had 2-12 times bone scintigraphy respectively.55 cases were identified with bone metastases,45 males and 10 females.42 cases had multiple bone metastases.13 cases had solitary bone metastases.Metastatic bone lesions manifested increased uptake in 35 cases,increased and defect in 15 cases and defect in only 5 cases.The parts of bone metastases in order of frequency were pelvic bones,lumber vertebra,ribs,femur,thoracic vertebra,skull,humerus,scapula,sternum,tibia and calcanueus.The univariate analysis and multivariate Cox proportional hazards regression models showed bone pain and pathological stage related to bone metastasis,whereas sex,age,pathological type and pathological grade had no relationship with bone metastases.Conclusion Bone scintigraphy has important clinical value in the postoperative follow-up of the patients with RCC,those with bone pain or late pathological stage should undergo bone scintigraphy as early as possible so as to detect the metastatic lesions timely.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第25期2569-2571,2574,共4页 Chongqing medicine
基金 国家自然科学基金资助项目(30870729 81071183) 国家重大科学仪器设备开发专项(2011YQ03011409)
关键词 放射性核素显像 肾细胞 手术后期间 肿瘤转移 radionuclide imaging carcinoma,renal cell postoperative period neoplasm metastasis
  • 相关文献

参考文献15

  • 1李少林,王荣福.核医学[M].7版.北京:人民卫生出版社,2008:88.
  • 2Koga S,Tsuda S,Nishikido M,et al. The diagnostic value of bone scan in patients with renal cell carcinoma[J]. J Urol, 2001,166 (6): 2126-2128.
  • 3Cangiano T, Liao J, Naitoh J, et al. Sarcomatoid renal cell carcinoma. Biologic behaviour, prognosis and response to combined surgical resection and immunotherapy[J]. J Clin Oncol, 1999,17(2):523-528.
  • 4肾癌骨转移临床诊疗专家共识(2008版)[J].中华肿瘤杂志,2010,32(4):317-319. 被引量:8
  • 5赵祯,李林,赵丽霞.SPECT/CT融合显像诊断恶性肿瘤骨转移的价值[J].中国临床医学影像杂志,2008,19(3):203-204. 被引量:12
  • 6Nakatani K, Nakamoto Y, Saga T, et al. The potential clinical value of FDG-PET for recurrent renal cell carcinoma[J]. Eur J Radiol,2011,79(1) :29-35.
  • 7Chua S,Gnanasegaran G,Cook GJ. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors) : role of SPECT and PET in imaging bone metas- tases[J ]. Semin Nucl Med, 2009,39 (6) : 416-430.
  • 8Rajarubendra N, Bolton D, Lawrentschuk N. Diagnosis of bone metastases in urological malignancies--an update[J]. Urology, 2010,76 (4) : 782-790.
  • 9Bailey E, HoShon I, Roach P. Additional benefit of SPECT/ CT in bone scanning of metastatic renal cell carcinoma [J]. Clin Nucl Med,2007,32(5) :411-414.
  • 10Frank W, Stuhldreher D, Saffrin R, et al. Stage IV renal cell carcinoma[J]. J Urol,1994,152(6) :1998-1999.

二级参考文献40

  • 1岳明纲,王茜,秦淑玲,张彩群,聂玉新,王玉,梁铁军.骨断层显像与同机定位CT进行图像融合对诊断脊柱骨转移性病变的临床应用价值[J].中国临床医学影像杂志,2006,17(4):202-204. 被引量:17
  • 2李林,赵祯,郭兴.恶性肿瘤骨转移影像学诊断[J].中华核医学杂志,2006,26(5):315-318. 被引量:57
  • 3郑建国,赵波沣,于治国,鲁振萍,姚稚明,屈婉莹.SPECT/CT融合显像在肋骨病变良、恶性鉴别诊断中的应用[J].中国医学影像技术,2007,23(6):925-928. 被引量:42
  • 4Zekri J, Ahmed N, Coleman RE, et al. The skeletal metastatic complications of renal cell carcinoma. Int J Oncol, 2001, 19: 379-382.
  • 5Han KR, Pantuck AJ, Bui MH, et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology, 2003, 61.. 314 319.
  • 6Flanigan RC, Campbell SC, Clark JI, et al. Metastatic renal cell carcinoma. Curr Treat Options Oncol, 2003, 4:385-390.
  • 7Martel CL, Lara PN. Renal cell carcinoma: current status and future directions. Crit Rev Oncol Hematol, 2003, 45: 177- 190.
  • 8Koga S, Tsuda S, Nishikido M, et al. The diagnositic value of bone scan in patients with renal cell carcinoma. J Urol, 2001, 166:2126-2128.
  • 9Staudenherz A, Steiner B, Puig S, et al. Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma? Cancer, 1999, 85: 153- 155.
  • 10Seaman E, Goluboff ET, Ross S, et al. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma. Urology, 1996, 48: 692-695.

共引文献36

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部